Pharmacokinetics of Dabigatran Etexilate (Pradaxa®) During Haemodialysis

NCT01241539 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiovascular Diseases
Kidney Failure, Chronic

Interventions

DRUG: Dabigatran etexilate
DRUG: Dabigatran etexilate
DRUG: Dabigatran etexilate

Sponsor

Boehringer Ingelheim